SIRGs score may be a predictor of prognosis and immunotherapy response for esophagogastric junction adenocarcinoma

SIRGs score may be a predictor of prognosis and immunotherapy response for esophagogastric junction adenocarcinoma

BackgroundEsophagogastric junction adenocarcinoma (EGJA) is a special malignant tumor with unknown biological behavior. PD-1 checkpoint inhibitors have been recommended as first-line treatment for advanced EGJA patients. However, the biomarkers for predicting immunotherapy response remain controvers...

Full description

Bibliographic Details
Main Authors: Li-Ying OuYang, Zi-Jian Deng, Yu-Feng You, Jia-Ming Fang, Xi-Jie Chen, Jun-Jie Liu, Xian-Zhe Li, Lei Lian, Shi Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Immunology
Subjects:
esophagogastric junction adenocarcinoma
SIRGs score
prognosis
immunotherapy
tumor microenvironment
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.977894/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.977894/full

Similar Items